Phase 3-ready biotech developing in-licensed therapies for cancer.
Industry: Health Care
First Day Return: -7.1%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 04/02/2021 |
Offer Price | $17.00 |
Price Range $16.00 - $18.00 | |
Offer Shares (mm) | 7.4 |
Deal Size ($mm) | $125 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 04/22/2021 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $125 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Newark, CA, United States |
Founded | 2017 |
Employees at IPO | 17 |
Website www.rainthera.com |